Bioequivalence Study of Empagliflozin & Metformin HCL From Empagliform 12.5/1000 mg F.C.T (Hikma Pharma, Egypt) and Synjardy 12.5/1000 mg F.C.T (Boehringer Ingelheim International GmbH, Germany)
Clinical trial NCT05132023 · COMPLETED
Trial details
- NCT number
- NCT05132023
- Sponsor
- Genuine Research Center, Egypt
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-26
- Primary completion
- 2019-04-02
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.